RETROGRADE DISTRIBUTION OF A NEW 5-AMINOSALICYLIC ACID ENEMA IN PATIENTS WITH ULCERATIVE-COLITIS

被引:0
|
作者
ALMER, S [1 ]
EKBERG, S [1 ]
STROM, M [1 ]
机构
[1] LINKOPING UNIV,FAC HLTH SCI,DEPT NUCL MED,S-58185 LINKOPING,SWEDEN
来源
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE | 1992年 / 16卷 / 6-7期
关键词
5-AMINOSALICYLIC ACID; ENEMA; MESALAZINE; RETROGRADE SPREAD; 99M-TECHNETIUM; ULCERATIVE COLITIS;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Retrograde colonic distribution of a new 4 g 5-amino-salicylic acid enema (mesalazine) was investigated in seven patients with ulcerative colitis, five of whom were in remission. The enema was labeled with 99m-technetium and imaged by a gamma camera. A median of 86 percent (range 57-90) of the enema had spread beyond the rectum during the first two hours after administration. In four of the five examined patients with left-sided ulcerative colitis, the diseased mucosa was covered within the first 4 hours. In the fifth patient, with involvement of the descending colon, the enema did not spread beyond the very tortuous sigmoid colon 4 or even 8 hours after enema administration.
引用
收藏
页码:564 / 568
页数:5
相关论文
共 50 条
  • [21] Factors associated with low adherence to oral 5-aminosalicylic acid in patients with ulcerative colitis
    Lee, Jin
    Jee, Sam Ryong
    Kim, Hyung Wook
    Baek, Dong Hoon
    Song, Geun Am
    Moon, Won
    Park, Seun Ja
    Kim, Hyun Jin
    Lee, Jong Hoon
    Park, Jong Ha
    Kim, Tae Oh
    PLOS ONE, 2019, 14 (03):
  • [22] Synthesis and evaluation of a prodrug of 5-aminosalicylic acid for the treatment of ulcerative colitis
    Yan, Yan
    Ren, Fengling
    Wang, Pengchong
    Sun, Ying
    Xing, Jianfeng
    IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2019, 22 (12) : 1452 - 1461
  • [23] The Synergistic Effects of 5-Aminosalicylic Acid and Vorinostat in the Treatment of Ulcerative Colitis
    He, Long
    Wen, Shuting
    Zhong, Zhuotai
    Weng, Senhui
    Jiang, Qilong
    Mi, Hong
    Liu, Fengbin
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [24] Evaluating the effects of 5-aminosalicylic acid on tofacitinib treatment in ulcerative colitis
    Nishida, Yu
    Hosomi, Shuhei
    Fujimoto, Koji
    Kobayashi, Yumie
    Nakata, Rieko
    Maruyama, Hirotsugu
    Ominami, Masaki
    Nadatani, Yuji
    Fukunaga, Shusei
    Otani, Koji
    Tanaka, Fumio
    Fujiwara, Yasuhiro
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2025, 40 (01) : 108 - 114
  • [25] A new 5-aminosalicylic acid multi-unit dosage form for the therapy of ulcerative colitis
    Rudolph, MW
    Klein, S
    Beckert, TE
    Petereit, HU
    Dressman, JB
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2001, 51 (03) : 183 - 190
  • [26] Characteristics of Mucosa-Associated Microbiota in Ulcerative Colitis Patients with 5-Aminosalicylic Acid Intolerance
    Matsumoto, Hiroshi
    Sasahira, Momoyo
    Go, Tei Tei
    Yo, Shogen
    Ninomiya, Takehiro
    Osawa, Motoyasu
    Handa, Osamu
    Umegami, Eiji
    Inoue, Ryo
    Shiotani, Akiko
    BIOMEDICINES, 2024, 12 (09)
  • [27] Development of a Web-based concept for patients with ulcerative colitis and 5-aminosalicylic acid treatment
    Elkjaer, Margarita
    Burisch, Johan
    Avnstrom, Soren
    Lynge, Elsebeth
    Munkholm, Pia
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2010, 22 (06) : 695 - 704
  • [30] The Effects of 5-Aminosalicylic Acid on Janus Kinase Inhibitor Treatment in Ulcerative Colitis
    Dai, Cong
    Huang, Yu-hong
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2025, 40 (03) : 761 - 763